Jewish Hospital

Cincinnati, Ohio 45236

0 studies enrolling now · 14 studies all time

What they study most

Acute Graft-versus-host Disease, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Brain Infarction, Chronic Myelogenous Leukemia, Graft Versus Host Disease, Graft-versus-Host Disease, Hematologic Malignancies, Ischemic Attack, Transient, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, Patent Foramen Ovale

Studies at this site

• Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma — Completed
• AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
• Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies — Completed
• Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) — Completed
• Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair — Stopped early
• A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis — Completed
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early
• Trial of CPX-351 in Newly Diagnosed Elderly AML Patients — Completed
• Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease — Completed
• A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis — Stopped early
• Stem Cell Related Donor Safety Study — Completed
• DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma — Stopped early
• Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR) — Completed